Anti-oxLDL antibodies, homocysteine and apolipoproteins in primary antiphospholipid syndrome

Jugoslovenska Medicinska Biohemija

Volumn 25, Issue 2, 2006, Pages 167-172

  Bećarević, Mirjana ^a,b   Mirković, Duško ^a,b   Miljić, Predrag ^a   Andrejević, Sladana ^a   Obradović, Ivana ^a,b   Bonači Nikolić, Branka ^a   Majkić Singh, Nada ^a,b  

^a CLINICAL CENTER OF SERBIA   (Serbia)

^b Institut za Medicinsku Biohemiju   (Yugoslavia)

Author keywords

Anti oxLDL antibodies; Apolipoproteins; Atherothrombosis; Homocysteine; Primary antiphospholipid syndrome

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; AUTOANTIBODY; CARDIOLIPIN ANTIBODY; HOMOCYSTEINE; LUPUS ANTICOAGULANT;

ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEART INFARCTION; HUMAN; MALE; REVIEW; SEROLOGY; VEIN THROMBOSIS;

EID: 33646672442     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMB0602167B     Document Type: Review

References (18)

1. Gromnica-Ihle E, Schösler W. Antiphospholipid syndrome. Int Arch Allergy Immunol 2000; 123: 67-76.
2. Mackworth-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004; 136: 393
3. opes-Virella M. Lipoprotein autoantibodies: measurement and significance. Clin Diagn Lab Immunol 2003; 10 (4) 499-505.
4. Doggen CJM, Smith NL, Lemaitre RN, Heckbert SR, Rosendal FR, Psaty BM. Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol 2004; 24 (10): 1970-5.
5. Ridker PM. Beyond cholesterol: C-reactive protein and homocysteine as predictors of cardiovascular risk. In: Handbook of lipoprotein testing. Rifai N, Warnick GR, Dominiczak MH (ed). AACC Press 2002; 1-29.
6. Hankey GJ, Eikelboom JW, Ho WK, Van Bockxmeer FM. Clinical usefulness of plasma homocysteine in vascular disease. MJA 2004; 181: 314-8.
7. Ames PRJ. Medical Perspective. Antiphospholipid antibodies, thrombosis and atherosclerosis in systemic lupus erythematosus. A unifying »membrane stress syndrome« hypothesis. Lupus 1994; 3: 371-7.
8. Wilson WA, Gharavi AE, Koike T, et al. International statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999; 42 (7): 1309-11.
9. Brandt JT, Triplett DA, Alving B, Scharrer J. Criteria for the Diagnosis of Lupus Anticoagulans: An update on behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society of Thrombosis and Haemostasis. Thrombosis Haemostasis 1995; 74 (4): 1185-90.
10. Nicolo D, Monestier M. Antiphospholipid antibodies and atherosclerosis. Clin Immunol 2004; 112: 183-9.
11. Lefvert AK. Heterogenity of autoantibodies against cardiolipin and oxidatively modified low density lipoproteins revealed by human monoclonal antibodies. J Intern Med 2000; 247: 385-90.
12. Bećarević M, Andrejević S, Bonači- Nikolić B, Obradović I, Miljić P, Majkić-Singh N. Anti-oxLDL antibodies - marker for arterial thrombosis in antiphospholipid syndrome? Clin Lab 2005; 51 (5+6): 279-83.
13. Stauffenberger MT, Lange RA, Hillis LD, Cigarroa J, Hsu RM, Devaraj S, Jialal I. Hyperhomocysteinemia measured by immunoassay: a valid measure of coronary artery atherosclerosis. Arch Pathol Lab Med 2004; 128: 1236-6.
14. Avivi J, Lanir N, Hoffman R, Brener B. Hyperhomocysteinemia is common in patients with antiphospholipid syndrome and contributes to the expression of major thrombotic events. Blood Coagul Fibrinolysis 2002; 13 (2): 169-72.
15. Fialová L, Mikuliková L, Malbohan J, Benešová O, Štipek S, Zima T, Zwinger A. Antibodies against oxidized low density lipoproteins in pregnant women. Physiol Res 2002; 51: 355-61.
16. Lee RM, Brown MA, Ward K, Nelson L, Branch DW, Silver RM. Homocysteine levels in women with antiphospholipid syndrome and normal fertile controls. J Reprod Immunol 2004; 63 (1): 23-30.
17. Leys D. Atherothrombosis: a major health burden. Cerebrovasc Dis 2001; 1 Suppl 2: 1-4.
18. Bećarević M. Clinical significance of the determination of potential biomarkers for atherothrombosis in primary antiphospholipid syndrome. Thesis. Belgrade, Serbia and Montenegro: Faculty of Pharmacy, University of Belgrade 2005.